# Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.

> **NCT02785822** · PHASE4 · TERMINATED · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 19 (actual)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** hMG-HP
- **DRUG:** hFSH-HP

## Key facts

- **NCT ID:** NCT02785822
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-23
- **Primary completion:** 2018-05-09
- **Final completion:** 2018-05-09
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** Difficulties in recruitment
- **Last updated:** 2019-02-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02785822

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02785822, "Study to Compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in Patients With Polycystic Ovary Under a IVF/ICSI Cycle.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02785822. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*